Warberg Asset Management’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$13K Hold
2022
Q2
$11K Buy
2022
Q1
$20K Buy
2021
Q4
$18K Sell
2021
Q3
$49K Sell
2021
Q2
$252K Buy